Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125

This publication has 18 references indexed in Scilit:

• Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
  Gynecologic Oncology, 1998
• Stage IV Ovarian Cancer: Impact of Surgical Debulking1
  Gynecologic Oncology, 1997
• Cytoreduction for advanced ovarian cancer in perspective
  International Journal of Gynecologic Cancer, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• The Influence of Tumor Grade, Distribution, and Extent of Carcinomatosis in Minimal Residual Stage III Epithelial Ovarian Cancer after Optimal Primary Cytoreductive Surgery
  Gynecologic Oncology, 1994
• Surgical management of ovarian cancer
  Seminars in Surgical Oncology, 1994
• The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
  Gynecologic Oncology, 1992
• Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
  New England Journal of Medicine, 1990
• Adjuvant Therapy for Early-Stage Ovarian Cancer
  New England Journal of Medicine, 1990
• CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients
  Obstetrics & Gynecology, 1986